PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880645
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880645
The global monofilament absorbable sutures market is witnessing strong growth as surgical volumes rise worldwide and advanced wound closure solutions gain rapid acceptance. The market was valued at USD 559.3 million in 2024, is projected to increase to USD 584.1 million in 2025, and is anticipated to reach USD 932.7 million by 2032, expanding at a CAGR of 6.9% over the forecast period. These sutures, made from a single filament of synthetic or natural materials, dissolve naturally in the body and eliminate the need for removal, making them essential in internal and minimally invasive surgeries. In 2024, North America held a dominant market share of 32.33%, supported by advanced healthcare infrastructure and high surgical procedure volume.
Monofilament absorbable sutures are widely used in general surgery, orthopedics, cardiovascular procedures, and gynecology. Their smooth, single-strand design reduces tissue drag and minimizes inflammation, improving healing outcomes. Increasing global awareness around infection control and the shift towards minimally invasive procedures have further strengthened demand for these sutures.
Market Drivers
A key driver for market expansion is the rapid rise in global surgical procedures, spanning orthopedics, cardiology, obstetrics, and cosmetic surgery. Cesarean section rates continue escalating worldwide-Canada recorded 33.4% of deliveries by C-section in 2023, according to CIHI. Furthermore, the National Center for Biotechnology Information (NCBI) reports that around 400,000 coronary bypass surgeries are conducted annually. Such trends significantly increase consumption of monofilament absorbable sutures, which are crucial for internal wound closure.
Additionally, the aging global population is more susceptible to chronic diseases requiring surgical intervention, such as angioplasty, joint replacement, and organ transplantation. This factor further fuels long-term demand for absorbable sutures, especially those designed to reduce post-surgical discomfort and complication risks.
Market Restraints
Despite growth, the market faces challenges due to the rising adoption of alternative wound closure technologies, including surgical staplers, tissue adhesives, and hemostats. These methods offer advantages such as faster application, lower infection risks, and improved aesthetic outcomes. As per Suture Planet (February 2025), staplers provide faster closure and reduced tissue damage compared to sutures, which limits the use of monofilament absorbable sutures in specific surgical disciplines.
Price sensitivity in emerging markets, coupled with limited awareness of suture-related best practices, also hinders widespread adoption.
Market Opportunities
Developing countries across Asia, the Middle East, and Africa represent strong growth opportunities due to expanding healthcare infrastructure. Increasing investments in new hospitals, specialty centers, and surgical training facilities significantly boost suture demand. For instance, Al Qassimi Hospital in Sharjah adopted advanced cardiac simulation technology in 2024, while Inamdar Multispecialty Hospital in India opened a dedicated Dental & Face Surgery Clinic in 2025. As healthcare access improves, surgical volumes will rise, resulting in higher consumption of monofilament absorbable sutures.
Market Challenges
Post-surgical complications such as infection, hypersensitivity reactions, and granuloma formation continue to pose challenges. These issues may push surgeons toward non-absorbable or alternative closure systems. Moreover, stringent regulatory frameworks enforced by agencies like the FDA and EMA increase development time and cost, particularly for smaller manufacturers.
Key Trends
A major trend reshaping the market is the growing adoption of knotless absorbable sutures, especially for minimally invasive cardiovascular, orthopedic, and laparoscopic surgeries. These sutures reduce surgical site infections and eliminate knot-related complications. Clinical studies, such as the 2022 British Journal of Surgery report, highlight significant reductions in SSI rates when using knotless barbed sutures compared to conventional types. Additionally, antimicrobial-coated and bioengineered monofilament sutures are rapidly gaining traction.
Conclusion
With the market growing from USD 559.3 million in 2024 to USD 932.7 million by 2032, the monofilament absorbable sutures industry is set for sustained expansion driven by escalating surgical procedures, technological advancements, and broader healthcare access. While regulatory hurdles and competing technologies pose challenges, rising preference for minimally invasive solutions and improvements in suture design ensure strong long-term growth.
Segmentation By Type, Application, End-user, and Region
By Type * Natural
By Application * Gynecology
By End-user * Hospitals & ASCs
By Region * North America (By Type, by Application, by End-user, and by Country)
U.S.
Canada
Germany
U.K.
France
Italy
Spain
Scandinavia
Rest of Europe
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Brazil
Mexico
Rest of Latin America
GCC
South Africa
Rest of the Middle East & Africa